2910 Federal Register / Vol. 76, No. 11 / Tuesday, January 18, 2011 / Notices 

means and instrumentalities for the 

commission of deceptive acts and 

practices, and accordingly, themselves 

committed a deceptive act in violation 

of Section 5 of the FTC Act. 

The Commission also alleges that by 

stating that the NGBA and the NAGC 

endorsed Tested Green, respondents 

represented expressly or impliedly that 

they were independent from these 

organizations, when, in fact, they own 

and operate NGBA and NAGC. 

Therefore, respondents’ statement of 

endorsement by NGBA and NAGC was 

false and misleading, in violation of 

Section 5. Similarly, in light of 

respondents’ express and implied 

representation that these organizations 

were independent, respondents’ failure 

to disclose their relationship to NGBA 

and NAGC was deceptive, in violation 

of Section 5. 

Part I of the proposed order prohibits 

respondents from misrepresenting: (1) 

The fact that, or degree to which, they 

have, or a third party has, evaluated a 

product, package, service, practice, or 

program based on its environmental 

benefits or attributes; (2) that 

respondents have, or a third party has, 

the appropriate expertise to evaluate the 

environmental benefits or attributes of a 

product, package, service, practice, or 

program; (3) the number of certifications 

issued by respondents; and (4) that a 

product, package, certification, service, 

practice, or program is endorsed by an 

independent person or organization. 

Part II of the proposed order bars 

respondents, in connection with the 

labeling, advertising, marketing, 

promotion, offering for sale, sale, or 

distribution of any product, package, 

certification, service, practice, or 

program, from providing others with the 

means and instrumentalities to make, 

expressly or impliedly, any false or 

misleading statement. 

Part III of the proposed order bars 

respondents from making any 

representation, expressly or by 

implication, about any user or endorser 

of a product, package, certification, 

service, practice, or program, unless 

they clearly and prominently disclose a 

material connection with such user or 

endorser, where one exists. 

Parts IV through VIII of the proposed 

order are reporting and compliance 

provisions. Part IV requires respondents 

to retain documents relating to their 

compliance with the order. Part V 

requires dissemination of the order to 

all current and future principals, 

officers, directors, managers, employees, 

agents, and representatives having 

responsibilities relating to the subject 

matter of the order. Part VI ensures 

notification to the FTC of changes in 

respondent Nonprofit Management’s 

corporate status. Part VII mandates that 

respondent Claeys notify the FTC of any 

changes in his business affiliations or 

employment. Part VIII mandates that 

respondents submit a report to the 

Commission detailing their compliance 

with the order. Part IX provides that the 

order expires after twenty (20) years, 

with certain exceptions. 

The purpose of this analysis is to aid 

public comment on the proposed order. 

It is not intended to constitute an 

official interpretation of the proposed 

order or to modify its terms in any way. 

By direction of the Commission. 

Donald S. Clark, 

Secretary. 

[FR Doc. 2011–926 Filed 1–14–11; 8:45 am] 

BILLING CODE 6750–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Meeting of the National Vaccine 

Advisory Committee 

AGENCY: Office of the Assistant 

Secretary for Health, Office of the 

Secretary, Department of Health and 

Human Services. 

ACTION: Notice of meeting. 

SUMMARY: As stipulated by the Federal 

Advisory Committee Act, the 

Department of Health and Human 

Services (DHHS) is hereby giving notice 

that the National Vaccine Advisory 

Committee (NVAC) will hold a meeting. 

The meeting is open to the public. Preregistration is required for both public 

attendance and comment. Individuals 

who wish to attend the meeting and/or 

participate in the public comment 

session should either e-mail 

nvpo@hhs.gov or call 202–690–5566 to 

register and provide name, organization, 

and e-mail address. 

DATES: The meeting will be held on 

February 16, 2011 from 8:30 a.m. to 5 

p.m., EDT, and February 17, 2011 from 

8:30 am to 4 p.m., EDT. 

ADDRESSES: Department of Health and 

Human Services; Hubert H. Humphrey 

Building, Room 800, 200 Independence 

Avenue, SW., Washington, DC 20201. 

FOR FURTHER INFORMATION CONTACT: 

National Vaccine Program Office, 

Department of Health and Human 

Services, Room 715–H, Hubert H. 

Humphrey Building, 200 Independence 

Avenue, SW., Washington, DC 20201. 

Phone: (202) 690–5566; Fax: (202) 260– 

1165; e-mail: nvpo@hhs.gov. 

SUPPLEMENTARY INFORMATION: Pursuant 

to Section 2101 of the Public Health 

Service Act (42 U.S.C. 300aa–1), the 

Secretary of Health and Human Services 

was mandated to establish the National 

Vaccine Program to achieve optimal 

prevention of human infectious diseases 

through immunization and to achieve 

optimal prevention against adverse 

reactions to vaccines. The National 

Vaccine Advisory Committee was 

established to provide advice and make 

recommendations to the Director of the 

National Vaccine Program on matters 

related to the program’s responsibilities. 

The Assistant Secretary for Health 

serves as Director of the National 

Vaccine Program. 

Topics to be discussed at the meeting 

include the National Vaccine Plan, 

Influenza 2010–2011 Season, H1N1 

Vaccine Safety, and other related issues. 

The meeting agenda will be posted on 

the Web site: http://www.hhs.gov/nvpo/ 

nvac at least one week prior to the 

meeting. Public attendance at the 

meeting is limited to space available. 

Individuals who plan to attend and 

need special assistance, such as sign 

language interpretation or other 

reasonable accommodations, should 

notify the National Vaccine Program 

Office at the address/phone listed above 

at least one week prior to the meeting. 

Members of the public will have the 

opportunity to provide comments at the 

meeting. Public comment will be 

limited to five minutes per speaker. 

Individuals who would like to submit 

written statements should e-mail or fax 

their comments to the National Vaccine 

Program Office at least five business 

days prior to the meeting. 

Dated: January 7, 2011. 

Bruce Gellin, 

Deputy Assistant Secretary for Health, 

Director, National Vaccine Program Office. 

[FR Doc. 2011–868 Filed 1–14–11; 8:45 am] 

BILLING CODE 4150–44–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

HIT Policy Committee’s Meaningful 

Use Workgroup Meetings; Notice of 

Meetings and Request for Comments 

AGENCY: Office of the National 

Coordinator for Health Information 

Technology, HHS. 

ACTION: Notice of Meetings and request 

for comments. 

This notice announces the 

forthcoming subcommittee meetings of a 

Federal advisory committee of the 

Office of the National Coordinator for 

Health Information Technology (ONC). 

The meeting will be open to the public. 

Name of Subcommittee: HIT Policy 

Committee Meaningful Use Workgroup. 

mstockstill on DSKH9S0YB1PROD with NOTICES